The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

The diabetes drug you've heard of for 60 years just revealed a secret — it's been working on your brain all along.

Novo Nordisk NVO announced that the FDA has approved Awiqli injection as the first and only once-weekly, long-acting basal ...

Metformin has been used for years to help people with Type 2 Diabetes control their blood sugar. Now, scientists have ...

Diabetes is one of the fastest-growing diseases in the world. We examine why diabetes is such a pervasive problem and explore ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly alternative.

Kresladi becomes the first FDA-approved gene therapy for children with severe LAD-I due to biallelic variants in ITGB2, and ...

The FDA has approved the first weekly insulin shot for adults with type 2 diabetes, offering a new alternative to daily injections. Dr. Todd Ellerin from South Shore Hospital explains.

Those who were misdiagnosed had higher healthcare utilization, suggesting potential benefits of broader autoantibody screening.

The risk for dementia is significantly higher in people with diabetes, with the greatest risk among those with type 1 disease ...